Evaluation of safety and efficacy of Tirofiban injection for treating acute ischemic stroke beyond standard time window

Evaluation of safety and efficacy of Tirofiban injection for treating acute ischemic stroke beyond standard time window

Abstract To evaluate the safety and efficacy of tirofiban in the treatment of acute ischemic stroke (AIS). Clinical data of 152 AIS patients with small vessel occlusion admitted in 2023 were retrospectively analyzed. These patients did not receive intravenous thrombolysis and endovascular treatment...

Full description

Saved in:
Bibliographic Details
Main Authors: Qian Yang, Qiaofeng He, Xinfa Mao, Weibing Fan, Xin Luo
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Acute ischemic stroke
Tirofiban
Standard time window
Mortality
Cerebral hemorrhage
Online Access:https://doi.org/10.1038/s41598-025-11882-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-11882-2

Similar Items